Henri R. Manasse, Jr. was Executive Vice President and Chief Executive Officer of the American Society of Health-System Pharmacists (ASHP) from July 1, 1997 until January 1, 2012 when he served as Executive Vice President and Chief Executive Officer Emeritus through June 30, 2012. He received his Bachelor of Science degree in pharmacy from the University of Illinois at the Medical Center, a Master of Arts degree in educational psychology from Loyola University of Chicago, and a Ph.D. in pharmacy administration from the University of Minnesota.  Prior to joining ASHP, Dr. Manasse was Vice President for Health Sciences, The University of Iowa, and Chairman of the Board of the University of Iowa Health System.  He previously served as interim Vice Chancellor for Health Services, University of Illinois at Chicago Medical Center.

 

His previous positions include dean, professor of pharmacy administration, and professor of health professions education at the College of Pharmacy, University of Illinois at Chicago. He has adjunct professor appointments at the University of Iowa, and the University of Maryland, and most recently was appointed Visiting Professor at the Peking Union Medical College Hospital in Beijing, China and Honorary Professor at Nottingham University, England. In 1996 he was elected to the Institute of Medicine of the National Academy of Sciences, and is the 2007 recipient of the Harvey A.K. Whitney Lecture Award. In 2012, he was awarded the prestigious Donald E. Francke Medal and Lectureship reflecting his work in international pharmacy.

In 2005, Dr. Manasse was elected as the Professional Secretary of the Board of Pharmaceutical Practice of the International Pharmaceutical Federation (FIP), and was named a 2008 FIP Fellow. He continues in his elected position as Professional Secretary of the International Pharmaceutical Federation (FIP) and expanded his work in FIPEd, a strategic initiative of FIP in global reform of pharmacy education.  He is also engaged in academic pursuits at the University of Illinois at Chicago, College of Pharmacy as Professor and Dean Emeritus and serves the Joint Commission International (JCI) as a member of the Steering Committee on Patient Safety. 

                                                                                            BIOGRAPHICAL SKETCH

Dima M. Qato, Pharm.D., MPH, Ph.D.

 

Dima M. Qato, PharmD, MPH, PhD is a clinical pharmacist and has been appointed as an Assistant Professor in the Department of Pharmacy Administration at the University of Illinois at Chicago College of Pharmacy (UIC COP).  She will also hold an appointment in the Department of  Pharmacy Practice and will be an affiliate faculty member in the Center for Pharmacoepidemiology and Pharmacoeconomics Research within the COP.  Prior to joining the UIC COP faculty, Dr. Qato was a Research Associate at the University of Chicago where she led several high profile projects related to medication use in older adults and minorities.  Dr. Qato’s primary research interests are aimed at improving access to, and use of, medications in vulnerable populations in the United States and abroad. Dr. Qato utilizes population-based methods to understand patterns and determinants of medication use, with a particular emphasis on aging, drug safety and disparities.

 

Dr. Qato is nationally recognized for her work on the unsafe use of prescription and non-prescription medications, including dietary supplements, in older adults in the United States. In 2008, this research was published in  JAMA  and received national and international media coverage. In addition, her work on disparities in the underuse of prescription medications published in Pharmacoepidemiology and Drug Safety has increased our understanding of the potential role of medications in health care disparities.  Dr. Qato is also interested in effecting scholarship/research to better understand the impact of pharmaceutical policy, drug development and models of pharmaceutical care on patterns of medication use.

 

 Dr. Qato has practiced community pharmacy in various settings and also served as a consultant for IMS health, an international pharmaceutical consulting firm, and for NORC at the University of Chicago. In 2001, she was the recipient of the Schweitzer fellowship and in 2002 she was granted the prestigious Fulbright Scholarship to study impediments to the appropriate use of medicines in Amman, Jordan. Dr. Qato earned her Pharm.D. from the UIC COP, her MPH from the Johns Hopkins Bloomberg School of Public Health, and her PhD in Public Health (Pharmacoepidemiology and Health Services Research) from the UIC School of Public Health.

 

            Dr. Qato’s unique academic and professional experience has enabled an interdisciplinary perspective that will continue to guide her research and clinical pharmacy practice. Her current research program seeks to examine the underlying mechanisms responsible for the underuse, overuse and inappropriate use of medications, how these patterns may influence health outcomes and health disparities, and what can be performed from a clinical (role of pharmacist and physician) and policy perspective to address these escalating problems to improve the quality of health care and population health.  Dr. Qato’s goal is to create a research program that will identify why medications are used, or not used, and how they can and should be used in the population to promote equity, longevity and good health.

 

 

Simon Pickard, Associate Professor, has been selected to serve  as the Co-Chair of the 2013 International Society of Quality of Life Research (ISOQOL) Annual Conference, Miami, FL, OCtober 9-13, 2013.

In 2011, Todd Lee, Simon Pickard, Glen Schumock and Surrey Walton were named honorary fellows in the UIC Institute for Health Research and Policy. The IHRP strives to advance understanding of the multiple levels of factors influencing health-related practices and behaviors, as well as influencing health practice and policy through interdisciplinary, collaborative research. The IHRP Fellows Program formally recognizes the contributions of the investigators who participate in and contribute to the Institute's mission.

By Sam Hostettler

The College of Pharmacy has received a $4.25 million federal grant to develop programs for safer medication use, including tools for detecting drug risks, training physicians, preventing medication errors and making drug information easier to understand.

 “Patients are not as safe as they should be,” says Bruce Lambert, professor of pharmacy administration and director of UIC’s Center for Education and Research on Therapeutics (CERTS), which will manage the program. “Medication errors and inappropriate use of medicines, by health professionals and patients, cause a great deal of harm.”

 The center will develop, test, and distribute tools and training materials in four areas: statistical methods for large-scale studies of comparative drug safety and effectiveness, opioid prescribing and dosing for acute pain; methods for preventing and detecting drug name confusion errors; and plain-language drug information.

 The grant is a continuation of a study that began in 2007, when UIC was named one of 10 new CERTS organizations throughout the nation. Funded by the Agency for Healthcare Research and Quality, part of the U.S. Health and Human Services department, UIC was tasked to design and test systems to optimize drug choice, drug monitoring and drug safety.

 The new grant is one of only six that were awarded in the current round of funding, and the only center of its kind headquartered in a college of pharmacy.

 The CERTS program was authorized by Congress in 1997 to examine the benefits, risks and cost-effectiveness of therapeutic products and to educate patients and caregivers.

 The mission of CERTS is to conduct research and provide education that will advance the optimal use of drugs, medical devices, and biological products; increase awareness of the benefits and risks of therapeutics; and improve quality while cutting the costs of care.

 UIC will continue to host the center, and will be assisted by Rush University Medical Center; Northwestern University; University of Chicago; the Brigham and Women’s Hospital, Boston; the Institute for Safe Medication Practices; Horsham, Pa.; and the National Patient Safety Foundation, Boston.

 

Sheila Allen, PharmD '03, clinical assistant professor and clinical pharmacist, received the New Practitioner Leadership Award from the Illinois Council of Health-System Pharmacists. She was recognized at the organization's annual meeting in September.

Denys T. Lau, Ph.D., Associate Professor,  has been elected as the Secretary, American Public Health Association Aging and Public Health Section, August 2011.

James W. Shaw, Pharm.D., Ph.D., MPH, Assistant Professor, has submitted his resignation to become the Senior Manager, Global Health Economics and Outcomes Research (HEOR), Abbott Laboratories beginning August 1, 2011.    Dr. Shaw joined the faculty of the Department of Pharmacy Administration, October 2006, and made a significant contribution through his research and scholarship.  His poster, co-authored with Dr. Simon Pickard, titled, "Multinational evaluation of conditional medium models of EQ-5D health state preferences," was selected as the 2010 Best Policy Research Poster of the Year, at the 17th Annual International Society of Quality of Life (ISOQOL) Research Conference, London, England.  He will be missed and his faculty colleagues and graduate students wish him much success in his new position. 

Dan Touchette, assistant professor of pharmacoeconomics, was appointed American College of Clinical Pharmacy Practice-Based Research Network Director as of Jan. 1. He is a longtime member and fellow in the College.